This invention relates to methods and apparatus for selecting the power of an intraocular lens to be implanted into an eye.
The history of intraocular lens implantation dates back to 1949 when an initial attempt to replace a diseased lens with an artificial one resulted in a poor outcome with an error of −24.0 diopter (D). Nevertheless, this set the stage for continuous advances in the field of ophthalmology, leading to the common practice of “standard-of-care” lens implantation we see today. The technology of cataract surgery has witnessed an impressive development through constant innovation of surgical technique and instrumentation, lens material and design, and just as importantly, ever improving methodology for calculating and predicting the power of the lens implant necessary to achieve desired postoperative refractive outcome. In the 1960s Fyodorov was the first scientist to publish a formula for predicting the power of the intraocular lenses (IOLs) based on geometrical optics incorporating two very important preoperative anatomical parameters of the ocular system. A-scan derived axial length of the eye and keratometry measurements of the cornea, Feodorov S N, Kolinko A L. Estimation of optical power of the intraocular lens. Vestn. Oftamol; 80(4):27-31 (1967). Colenbrander published the first formula written in English in 1973. Colenbrander, Calculation of the Power of an Iris-Clip Lens for Distance Vision, Br. J. Ophthal. 57:735-40 (1973). Many further improvements followed these pioneering efforts. Binkhorst described a derivative formula in the 1970s. Binkhorst R D., The optical design of intraocular lens implants. Ophthalmic Surg 1975;6(3):17-31. Binkhorst, Power of the Pre-Pupillary Pseudoshakos, B.J.O. 56:332-37, (1972)). Modifications of the Colenbrander formula were implemented by Dr. Hoffer with further improvement of accuracy across the different axial length ranges. Hoffer K J. Mathematics and computers in intraocular lens calculation. Am Intra-Ocular Implant Soc J 1975; 1(1):4-5). In 1980, Sanders, Retzlaff and Kraff derived a regression formula which has sustained many subsequent updates and modifications. Further refinements were achieved with the second generation formulas which had better precision over a wider range of anatomic parameters, but all used axial length and corneal curvature (keratometry) as the main predictive variable in their models. Sanders, J. Retzlaff & M. C. Kraff, Comparison of the SRK II Formula and the Other Second Generation Formulas, J. Cataract & Refractive Surg. 14(3):136-41 (1988). Olsen, T., Theoretical Approach to IOL Calculation Using Gaussian Optics, J. Cataract & Refractive Surg. 13:141-45 (1987). Holladay, T. C. Praeger, T. Y. Chandler & K. H. Musgrove, A Three-Party System for Refining Intraocular Lens Power Calculations, J. Cataract & Refractive Surg. 14:17-24 (1988). J. T. Thompson, A. E. Maumenee & C. C. Baker, A New Posterior Chamber Intraocular Lens Formula for Axial Myopes, Ophthal. 91:484-88 (1984). Various improvements in making preoperative anatomic-based estimates of IOL power have been described in the patent literature (e.g., U.S. Pat. Nos. 6,634,751, 5,968,095, and 5,282,852).
The shortcomings of current technology are multifold. Even in the ideal and most simplified clinical setting, about 10-20% of patients remain with at least 1.0 diopter refractive error after surgery. In about 3-5% of cases this residual can be as high as 2 diopters. Also, traditional IOL estimation techniques based on axial length and corneal curvature produce even greater inaccuracy when the cataract surgery is done after vision correcting refractive surgery (e.g., Lasik, Lasek, wavefront and other similar corrective procedures). In this setting, a larger residual error can result (e.g., more than about 80% of such cases have about 1-1.5 diopter error). Reliance on anatomic measurements is even more problematic for a patient whose eye shape is at the extreme end of the range of an anatomic parameter.
Autoretinoscopy has been traditionally used for determination of the optical state of the ocular system in an office visit. In this office setting, autoretinoscopy is used as an objective measurement to guide the subjective testing and estimation of the power for corrective eye glass prescription. In this setting, an autorefractor based on the principle of automated retinoscopy, is used with the eye in the phakic state (i.e., with the native lens in its native position). A number of widely available autoretinoscopes are employed with the patient in a sitting position in front of the apparatus.
In recent years, very significant advances have been made in IOL surgical techniques and instrumentation (e.g., microincision techniques for quick and controlled cataract surgery), but IOL power has continued to be estimated preoperatively using anatomic measurements.
The problems associated with current methods for IOL power estimation lie in the reliance on preoperative measurements, e.g., corneal curvature and axial length. These parameters can change significantly after the eye has been manipulated. For example, the curvature of the cornea and its optical properties change after incisions and intraocular procedures. Current models extrapolate the effective lens position of the implant through lens-associated constants, such as the A-constant, which are inherent to the specific lens design, but not to the particular anatomy of each eye, and therefore not individually customized to each surgical case. The current methods, because they only approximate the optical deficiency of the eye after lens extraction, lead to residual errors in lens power.
In a first aspect, the invention features a method for selecting the power of an intraocular lens, comprising extracting the native lens, performing autorefraction on the aphakic eye to provide one or more aphakic refraction measurements, and determining the power of the intraocular lens from the one or more aphakic refraction measurements.
Preferred implementations of this aspect of the invention may incorporate one or more of the following. The autorefraction may be performed with the patient in the same position in which the native lens was extracted. The position of the patient may be the supine position. The method may be used for patients that have previously undergone vision correcting refractive surgery. Determining the power of the intraocular lens may comprise using a predictive model that is an empirically derived relationship between the autorefraction measurements and the power of the intraocular lens. Determining the power of the intraocular lens may comprise using a predictive model that is a theoretically derived relationship between the autorefraction measurements and the power of the intraocular lens. The native lens may be extracted using a surgical microscope and the autorefraction may be performed using an autorefraction device configured to be moved into place for making autorefraction measurements following extraction of the native lens using the surgical microscope. The autorefraction may comprise making a plurality of autorefraction measurements and averaging the measurements. Determining the power of the intraocular lens may comprise determining the power from the one or more autorefractive measurements and from other parameters. The other parameters may include preoperative anatomic measurements of the eye. They may also include one or more of the following: intraocular pressure, intraoperative axial length, intraoperative keratometry, preoperative keratometry, preoperative axial length, intraoperative anterior chamber depth, or preoperative anterior chamber depth.
In a second aspect, the invention features apparatus for performing intraocular implant surgery, comprising surgical apparatus for performing intraocular implant surgery, an autorefraction device associated with the surgical apparatus, wherein the autorefraction device is configured to perform autorefraction on the aphakic eye to provide one or more aphakic refraction measurements, and a processor connected to the autorefraction device, wherein the processor is configured to process the aphakic refraction measurements and provide the user of the apparatus with information regarding the power of the intraocular lens.
Preferred implementations of this aspect of the invention may incorporate one or more of the following. The apparatus may further comprise a display for providing the user of the apparatus with the information regarding the power of the intraocular lens. The autorefraction device may be attached to or integrated with the surgical apparatus. The surgical apparatus may be a surgical microscope and the autorefraction device may comprise an autorefraction device configured to be moved into place for making refraction measurements following extraction of the native lens using the surgical microscope. The autorefraction device may be a portable autorefraction device that is used while a patient is in the supine position following surgical extraction of the lens. The autorefraction device may comprise a retinoscope. The autorefraction device may comprise a wavefront-based autorefraction device. The autorefraction device may comprise apparatus for measuring the aphakic dioptric state, the deficiency of the ocular system, or both the aphakic dioptric state and the deficiency of the ocular system. The autorefraction device may comprise or work in combination with an external lens, contact lens, intraocular lens, or other component with refractive or medium properties positioned along the optical axis along an autorefraction measurement trajectory. The surgical apparatus may comprise a surgical microscope that includes an ocular piece or display for centration and positioning and a toggle for XYZ movement, and wherein the autorefraction device may be positioned and configured so that movement of the toggle can adjust the position of the autorefraction device relative to the eye.
Among the many advantages of the invention (some of which may be achieved only in some of its various aspects and implementations) are the following: Greater precision is possible in estimating required IOL power, and thus there is less residual refractive error. It is possible to achieve reductions in the complexity and cost associated with IOL implantation surgery (e.g., it may be possible to eliminate the need for expensive equipment such as an A-scan biometry device and a keratometer, as well as the need for a separate pre-operative patient visit at which pre-operative eye measurements are made). The invention makes it possible to break away from the conventional preoperative anatomical approaches derived from Feodorov's original work in 1967. New refractive measurement technology can be used to predict the power of the intraocular lens. Anatomic parameters such as preoperative axial length and keratometry are no longer essential to the process of estimating the power of the intraocular lens (but these parameters, as well as others, may, in some implementations, be used in combination with the intraoperative autorefraction measurements). Relying on intraoperative measurement of the aphakic refractive state of the eye after lens extraction has the advantage that it measures the optical deficiency of the ocular system without the confounding interference of the native lens. Modern retinoscopy technology can be adapted to cataract surgery immediately after extraction of the cataract, when the eye is transiently aphakic; in this state, the cornea is the primary refractive medium and the optical system of the eye is in a unique state of non-interference by the lenticular optical component. When an autorefraction or other form of retinoscopy is done before a lens is implanted, the measurements are primed to correlate closely with the missing intraocular lens power. From these measurements the surgeon one can derive, correlate and calculate the parameters of the lens to be inserted. The method can be used solely for the purposes described or in combination with other ocular measurements and parameters obtained prior or during surgery to optimize accuracy and precision.
Other features and advantages of the invention will be found in the detailed description, drawings, and claims.
There are a great many possible implementations of the invention, too many to describe herein. Some possible implementations that are presently preferred are described below. It cannot be emphasized too strongly, however, that these are descriptions of implementations of the invention, and not descriptions of the invention, which is not limited to the detailed implementations described in this section but is described in broader terms in the claims.
The power of the intraocular lens can be derived from the refraction measurements. One possible method for deriving the intraocular lens power is to use an empirically derived relationship, which could be called a predictive IOL model, that relates the refraction measurements to the IOL power. This can be done, for example, by first calculating the aphakic spherical equivalent of the refraction measurements from the standard formula:
Spherical Equiv=Measured Spherical Power+½ Measured Cylindrical Power,
wherein Spherical Equiv is the aphakic spherical equivalent, Measured Spherical Power is the average of the spherical power measurements made using autorefraction, and Measured Cylindrical Power is the average of the cylindrical power measurements made using autorefraction. Next, the following empirically derived relationship may be used to relate the aphakic spherical equivalent to the IOL power:
IOL Power=A+c+b*(Spherical Equiv),
wherein A is the lens specific constant (and depends on the type of intraocular lens being implanted), c is an empirically derived constant, and b is the empirically derived linear correlation coefficient.
The two empirically derived coefficients c, b may be derived using a statistical regression analysis of data relating IOL power to autorefraction measurement of the spherical equivalent. For example, the regression analysis may be performed on data collected from a large population of patients (e.g., one hundred patients). For each patient, the data comprise the IOL Power selected using conventional preoperative measurements and the spherical equivalent from an intraoperative autorefraction.
Other relationships between the refraction measurements and the IOL power may also be used, and the necessary constants and coefficients derived either empirically or theoretically. One alternative, of course, is to simply combine the two formulas as follows:
IOL Power=A+c+b*(Measured Spherical Power+½ Measured Cylindrical Power),
Varying the vertex distance of autorefraction or modifying the optical media along the optical path (e.g., by inserting a different material into the anterior chamber of the eye, or by placing a temporary lens in or near the eye) can alter the parametric variables of the relationship.
In some implementations, the above formulation can be improved with additional variables to achieve better precision. Parameters such as intraocular pressure, intraoperative axial length, intraoperative keratometry, preoperative keratometry, preoperative axial length, intra and preoperative anterior chamber depth can be used as supplementary correlates in the predictive model, in order to refine the IOL power. For example, the following relationship could be used:
IOL Power=A+c+b*(Spherical Equiv)+d*(Axial Length)+f*(Average Keratometry)+g*(Intraoperative Pressure)
In one implementation, both the surgery and the autorefraction are performed using standard available equipment. A standard surgical microscope is used for extraction of the native lens, and a standard portable autorefraction device (e.g., a Nikon Retinomax) is used for autorefraction. Both procedures may be performed while the patient remains in the same supine position. The refraction measurements are read from the autorefraction device, and the IOL power is calculated using a formula such as one of those given above.
An alternative to the arrangement shown in
The equipment of
Many other implementations of the invention other than those described above are within the invention, which is defined by the following claims. For example, as earlier noted, completely separate surgical and autorefraction equipment may be used (e.g., with the microscope moved away, and the autorefraction equipment moved into place), and the IOL measurement may be calculated from the refraction measurements without using a special processor or display unit. Autorefraction may also be used after the intraocular lens is implanted (pseudophakic eye), to confirm whether a satisfactory choice has been made for the IOL power. If the autorefraction shows a residual error, the surgeon could immediately remove the implanted lens, and substitute another. Various types of autorefraction may be used to make the intraoperative refraction measurement of the aphakic eye.
This application is a divisional application of and claims priority to U.S. application Ser. No. 10/820,635, filed on Apr. 8, 2004 now U.S. Pat. No. 7,556,378. This application also claims priority to U.S. Provisional Application Ser. No. 60/461,429, filed on Apr. 10, 2003. The disclosures of the prior applications are considered part of (and are incorporated by reference in) the disclosure of this application.
Number | Name | Date | Kind |
---|---|---|---|
4125320 | Rassow | Nov 1978 | A |
4172662 | Vogel | Oct 1979 | A |
4173398 | Okamoto et al. | Nov 1979 | A |
4293198 | Kohayakawa et al. | Oct 1981 | A |
4353625 | Nohda et al. | Oct 1982 | A |
4372655 | Matsumura et al. | Feb 1983 | A |
4376573 | Matsumura et al. | Mar 1983 | A |
4390255 | Nohda et al. | Jun 1983 | A |
4421391 | Matsumura et al. | Dec 1983 | A |
4459027 | Kafri et al. | Jul 1984 | A |
4541697 | Ramijan | Sep 1985 | A |
4640596 | Humphrey | Feb 1987 | A |
4650301 | Humphrey | Mar 1987 | A |
4669835 | Humphrey | Jun 1987 | A |
4692003 | Adachi et al. | Sep 1987 | A |
4710193 | Volk | Dec 1987 | A |
4721379 | L'Esperance | Jan 1988 | A |
4730917 | Krueger | Mar 1988 | A |
4911711 | Telfair et al. | Mar 1990 | A |
4964715 | Richards | Oct 1990 | A |
4984883 | Winocur | Jan 1991 | A |
4995716 | Warnicki et al. | Feb 1991 | A |
5080477 | Adachi | Jan 1992 | A |
5157427 | Humphrey | Oct 1992 | A |
5164750 | Adachi | Nov 1992 | A |
5206672 | Rowe | Apr 1993 | A |
5208619 | Campbell | May 1993 | A |
5223863 | Heine | Jun 1993 | A |
5252999 | Sukigara | Oct 1993 | A |
5258791 | Penny et al. | Nov 1993 | A |
5270749 | Okumura | Dec 1993 | A |
5282852 | Capetan et al. | Feb 1994 | A |
5294971 | Braunecker et al. | Mar 1994 | A |
5307097 | Baker | Apr 1994 | A |
5329322 | Yancey | Jul 1994 | A |
5374193 | Trachtman | Dec 1994 | A |
5450143 | Rowe et al. | Sep 1995 | A |
5455645 | Berger et al. | Oct 1995 | A |
5493109 | Wei et al. | Feb 1996 | A |
5576780 | Yancey | Nov 1996 | A |
5777719 | Williams et al. | Jul 1998 | A |
5796463 | Bullimore | Aug 1998 | A |
5800533 | Eggleston et al. | Sep 1998 | A |
5861937 | Fujieda | Jan 1999 | A |
5909268 | Isogai et al. | Jun 1999 | A |
5936706 | Takagi | Aug 1999 | A |
5949521 | Williams et al. | Sep 1999 | A |
5963300 | Horwitz | Oct 1999 | A |
5968095 | Norrby | Oct 1999 | A |
5994687 | Chanteloup et al. | Nov 1999 | A |
6002484 | Rozema et al. | Dec 1999 | A |
6004313 | Shimmick et al. | Dec 1999 | A |
6007204 | Fahrenkrug et al. | Dec 1999 | A |
6042232 | Luce et al. | Mar 2000 | A |
6043885 | Mazuet et al. | Mar 2000 | A |
6050687 | Bille et al. | Apr 2000 | A |
6086204 | Magnante | Jul 2000 | A |
6095651 | Williams et al. | Aug 2000 | A |
6096077 | Callahan et al. | Aug 2000 | A |
6155684 | Bille et al. | Dec 2000 | A |
6199986 | Williams et al. | Mar 2001 | B1 |
6251101 | Glockler | Jun 2001 | B1 |
6262328 | Wicks et al. | Jul 2001 | B1 |
6264328 | Williams et al. | Jul 2001 | B1 |
6270221 | Liang et al. | Aug 2001 | B1 |
6271915 | Frey et al. | Aug 2001 | B1 |
6275718 | Lempert | Aug 2001 | B1 |
6299311 | Williams et al. | Oct 2001 | B1 |
6299618 | Sugiura | Oct 2001 | B1 |
6338559 | Williams et al. | Jan 2002 | B1 |
6379005 | Williams et al. | Apr 2002 | B1 |
6382793 | Lai et al. | May 2002 | B1 |
6382794 | Lai et al. | May 2002 | B1 |
6382795 | Lai | May 2002 | B1 |
6394605 | Campin et al. | May 2002 | B1 |
6409345 | Molebny et al. | Jun 2002 | B1 |
6419671 | Lemberg | Jul 2002 | B1 |
6439720 | Graves et al. | Aug 2002 | B1 |
6460997 | Frey et al. | Oct 2002 | B1 |
6497483 | Frey et al. | Dec 2002 | B2 |
6508812 | Williams et al. | Jan 2003 | B1 |
6550917 | Neal et al. | Apr 2003 | B1 |
6570143 | Neil et al. | May 2003 | B1 |
6572230 | Levine | Jun 2003 | B2 |
6575572 | Lai et al. | Jun 2003 | B2 |
6578963 | Pettit | Jun 2003 | B2 |
6585723 | Sumiya | Jul 2003 | B1 |
6588902 | Isogai | Jul 2003 | B2 |
6598975 | Liang et al. | Jul 2003 | B2 |
6601956 | Jean et al. | Aug 2003 | B1 |
6609793 | Norrby et al. | Aug 2003 | B2 |
6609794 | Levine | Aug 2003 | B2 |
6626535 | Altmann | Sep 2003 | B2 |
6626538 | Arrowsmith | Sep 2003 | B1 |
6634751 | Turner et al. | Oct 2003 | B2 |
6637884 | Martino | Oct 2003 | B2 |
6658282 | Eagan et al. | Dec 2003 | B1 |
6679606 | Campin et al. | Jan 2004 | B2 |
6685319 | Watson et al. | Feb 2004 | B2 |
6702806 | Gray et al. | Mar 2004 | B2 |
6705729 | Piers et al. | Mar 2004 | B2 |
6736509 | Martino et al. | May 2004 | B2 |
6736510 | Van Heugten | May 2004 | B1 |
6739721 | Altmann | May 2004 | B2 |
6761454 | Lai et al. | Jul 2004 | B2 |
6781681 | Horwitz | Aug 2004 | B2 |
6786603 | Altmann | Sep 2004 | B2 |
6793654 | Lemberg | Sep 2004 | B2 |
6827444 | Williams et al. | Dec 2004 | B2 |
6836374 | Esch et al. | Dec 2004 | B2 |
6905641 | Platt et al. | Jun 2005 | B2 |
6908196 | Herekar et al. | Jun 2005 | B2 |
6926710 | Cox et al. | Aug 2005 | B2 |
6948818 | Williams et al. | Sep 2005 | B2 |
6997555 | Dick et al. | Feb 2006 | B2 |
7018376 | Webb | Mar 2006 | B2 |
7034949 | Horwitz | Apr 2006 | B2 |
7044602 | Chernyak | May 2006 | B2 |
7044604 | Arrowsmith | May 2006 | B1 |
7057806 | Atkinson | Jun 2006 | B2 |
7066928 | Dick et al. | Jun 2006 | B2 |
7068439 | Esch et al. | Jun 2006 | B2 |
7070276 | Koretz | Jul 2006 | B2 |
7077522 | Williams | Jul 2006 | B2 |
7111938 | Andino et al. | Sep 2006 | B2 |
7182780 | Terwee et al. | Feb 2007 | B2 |
7255442 | Bucourt et al. | Aug 2007 | B2 |
7303281 | Wakil et al. | Dec 2007 | B2 |
7336371 | Haidner et al. | Feb 2008 | B1 |
7341348 | Eagan | Mar 2008 | B2 |
7350920 | Levine | Apr 2008 | B2 |
7357509 | Williams et al. | Apr 2008 | B2 |
7377641 | Piers et al. | May 2008 | B2 |
7380942 | Molebny et al. | Jun 2008 | B2 |
7401919 | Vogelsang et al. | Jul 2008 | B2 |
7406263 | Graves et al. | Jul 2008 | B2 |
7416305 | Williams et al. | Aug 2008 | B2 |
7425067 | Warden et al. | Sep 2008 | B2 |
7448752 | Levine | Nov 2008 | B2 |
7455407 | Neal et al. | Nov 2008 | B2 |
7467869 | Kahlen | Dec 2008 | B2 |
7476248 | Harris et al. | Jan 2009 | B2 |
7490938 | Latkany | Feb 2009 | B2 |
7490940 | Lai et al. | Feb 2009 | B2 |
7517087 | Dick et al. | Apr 2009 | B2 |
7543937 | Piers et al. | Jun 2009 | B2 |
7556378 | Ianchulev | Jul 2009 | B1 |
20010041884 | Frey et al. | Nov 2001 | A1 |
20020016629 | Sandstedt et al. | Feb 2002 | A1 |
20020082629 | Cox et al. | Jun 2002 | A1 |
20020105617 | Norrby et al. | Aug 2002 | A1 |
20020107567 | Terwee et al. | Aug 2002 | A1 |
20020118349 | Yang et al. | Aug 2002 | A1 |
20020135736 | Stark et al. | Sep 2002 | A1 |
20020154272 | Shevlin | Oct 2002 | A1 |
20020158508 | Watanabe | Oct 2002 | A1 |
20020163623 | Hirohara et al. | Nov 2002 | A1 |
20030007127 | Levine | Jan 2003 | A1 |
20030009156 | Levine | Jan 2003 | A1 |
20030025080 | Sting et al. | Feb 2003 | A1 |
20030174281 | Herekar et al. | Sep 2003 | A1 |
20030223037 | Chernyak | Dec 2003 | A1 |
20030230710 | Wolleschensky et al. | Dec 2003 | A1 |
20040088050 | Norrby et al. | May 2004 | A1 |
20040156014 | Piers et al. | Aug 2004 | A1 |
20040167622 | Sunalp et al. | Aug 2004 | A1 |
20040176753 | Dick et al. | Sep 2004 | A1 |
20040189938 | Eagan | Sep 2004 | A1 |
20040223214 | Atkinson | Nov 2004 | A1 |
20040263785 | Chernyak | Dec 2004 | A1 |
20050105044 | Warden et al. | May 2005 | A1 |
20050117117 | Bourla | Jun 2005 | A1 |
20050203422 | Wei | Sep 2005 | A1 |
20050225725 | Warden et al. | Oct 2005 | A1 |
20050241653 | Van Heugten | Nov 2005 | A1 |
20050243276 | Van Heugten et al. | Nov 2005 | A1 |
20050251115 | Cox et al. | Nov 2005 | A1 |
20050278004 | Steinert et al. | Dec 2005 | A1 |
20080231809 | Haigis | Sep 2008 | A1 |
20090002628 | Williams et al. | Jan 2009 | A1 |
20090036980 | Norrby et al. | Feb 2009 | A1 |
20090103050 | Michaels | Apr 2009 | A1 |
20090109401 | Van Heugten | Apr 2009 | A1 |
20090164007 | Van Heugten | Jun 2009 | A1 |
20100030225 | Ianchulev | Feb 2010 | A1 |
20100036386 | Ianchulev | Feb 2010 | A1 |
20100042210 | Ianchulev | Feb 2010 | A1 |
Number | Date | Country |
---|---|---|
0931504 | Jul 1999 | EP |
138282 | Jul 2004 | IL |
11-24434 | May 1989 | JP |
9-122075 | May 1997 | JP |
10-272100 | Oct 1998 | JP |
2000-139996 | May 2000 | JP |
2001-507258 | Jun 2001 | JP |
2001-314372 | Nov 2001 | JP |
2002-306418 | Oct 2002 | JP |
2003-509731 | Mar 2003 | JP |
2003-102689 | Apr 2003 | JP |
WO 9201417 | Feb 1992 | WO |
WO 9622506 | Jul 1996 | WO |
WO 9827863 | Jul 1998 | WO |
WO 0106914 | Feb 2001 | WO |
WO 0121061 | Mar 2001 | WO |
WO 0126591 | Apr 2001 | WO |
WO 0158339 | Aug 2001 | WO |
WO 0217775 | Mar 2002 | WO |
WO 03002047 | Jan 2003 | WO |
WO 03039356 | May 2003 | WO |
WO 03050472 | Jun 2003 | WO |
WO 03102498 | Dec 2003 | WO |
WO 2004093663 | Nov 2004 | WO |
WO 2005057252 | Jun 2005 | WO |
WO 2006081031 | Aug 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20100030225 A1 | Feb 2010 | US |
Number | Date | Country | |
---|---|---|---|
60461429 | Apr 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10820635 | Apr 2004 | US |
Child | 12499079 | US |